

Fundamental dimension Equity attribute | BAHLeader $78.32▼-0.32% Cap $9.42BP/E 12.1x QuantScore62/100 | BBAIPeer $2.13▲+0.24% Cap $1.02BP/E -12.5x QuantScore28/100 | CACIPeer $633.98▲+2.38% Cap $14.01BP/E 25.9x QuantScore54/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
84/100 |
16/100 |
94/100 |
Valuation Multiples, PEG & DCF upside | 100/100 | 0/100 | 69/100 |
Health Piotroski, Altman Z, leverage & liquidity | 56/100 | 67/100 | 40/100 |
Growth Revenue / earnings growth & margins | 10/100 | 7/100 | 30/100 |
Sentiment Analyst ratings, targets & revisions | 61/100 | 50/100 | 40/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 12.1x | -12.5x | 25.9x |
Forward P/E (next FY) | 12.2x | -8.1x | 19.0x |
EV / EBITDA (TTM) | 7.6x | -18.5x | 16.5x |
Price / Sales | 0.9x | 7.8x | 1.4x |
Price / Free Cash Flow | 9.6x | -13.8x | 11.0x |
PEG ratio | -7.95 | -0.07 | 3.38 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 4 / 9 | 6 / 9 |
Altman Z-Score | 3.29 (Safe) | 7.35 (Safe) | 2.95 (Grey) |
Total debt / equity | 0.25 | 0.03 | 1.14 |
Quick ratio | 1.4x | 5.7x | 1.6x |
Interest coverage | 10.6x | -10.4x | 3.9x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -6.4% | -19.3% | +10.9% |
Net income growth YoY | -9.0% | +0.6% | +7.2% |
Gross margin (TTM) | 30.4% | 27.9% | 21.6% |
Operating margin (FY) | 9.2% | -65.3% | 9.6% |
FCF margin (FY) | 8.5% | -36.3% | 8.2% |
5. Trailing price performancePrice change over period |
1M return | +6.1% | -23.9% | +2.8% |
3M return | +8.0% | -22.8% | +30.2% |
6M return | -0.5% | -42.4% | +22.7% |
Year to date | -7.2% | -60.6% | +19.0% |
1Y return | -14.3% | -69.8% | +8.3% |
3Y return | -34.6% | +60.2% | +96.5% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $326.19 +316.5% upside | $-0.8117 -138.1% premium | $1,006.36 +58.7% upside |
Wall Street consensus target | $90.43 +15.5% · range $65.00–$140.00 | $4.00 +87.8% · range $4.00–$4.00 | $754.00 +18.9% · range $550.00–$925.00 |
Consensus stance | 50% Buy36% Hold14% Sell | 25% Buy75% Hold0% Sell | 67% Buy30% Hold3% Sell |